SEC Form 4 · accession 0001480208-17-000004
Nuo Therapeutics, Inc. · AURX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Mintz
Director
Period of report
May 10, 2017
Accepted (ET)
Jul 10, 2017 · 8:59 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001091596
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Common Stock | $1.00 | May 10, 2017 | A | 18,750 | A | Jul 1, 2017 | May 10, 2027 | Common Stock | 18,750 | 18,750 | D |